| NCT ID | NCT03137472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Complex Regional Pain Syndromes |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2017-04-24 |
| Primary Completion | 2026-06-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2017-04-24 with a primary completion date of 2026-06-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.
Eligibility Criteria
Inclusion Criteria: * Age 18-70 * Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months * Average pain level reported on Numerical Rating Scale meets entry criteria * Ability to perform the experimental task and procedures. Exclusion Criteria: * MRI contraindication (metal implants or devices, claustrophobia) * TMS Contraindication (eg metal implant or devices near the site of stimulation) * History of epilepsy * History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher. * Neurologic illness that would interfere with brain integrity * Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher. * Currently pregnant or planning to become pregnant. * On going legal action or disability claim.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03137472 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Complex Regional Pain Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03137472 currently recruiting?
Yes, NCT03137472 is actively recruiting participants. Contact the research team at omar97@stanford.edu for enrollment information.
Where is the NCT03137472 trial being conducted?
This trial is being conducted at Redwood City, United States.
Who is sponsoring the NCT03137472 clinical trial?
NCT03137472 is sponsored by Stanford University. The trial plans to enroll 40 participants.